IDH1/2 Inhibitors in AML

preview_player
Показать описание
Dan Pollyea, MD, MS, reviews the role of IDH1 and IDH2 inhibitors in acute myeloid leukemia [AML], including for patients with myelodysplastic syndrome that has transformed to AML.

  1. OncLive
  2. cancer
  3. oncology
Рекомендации по теме
IDH1/2 Inhibitors in 0:06:35

IDH1/2 Inhibitors in AML

IDH1/2 Inhibitors for 0:05:47

IDH1/2 Inhibitors for AML

IDH1/2 inhibitors for 0:06:41

IDH1/2 inhibitors for AML

IDH1/2 inhibitors for 0:01:51

IDH1/2 inhibitors for upfront AML therapy and transfusion independence

Highlights on IDH1 0:02:06

Highlights on IDH1 and 2 inhibitors

Targeting IDH1/2 in 0:06:10

Targeting IDH1/2 in AML

Treatment strategies for 0:01:53

Treatment strategies for patients with IDH1/2-mutated AML ineligible for intensive chemotherapy

FLT3 and IDH1/2 0:03:23

FLT3 and IDH1/2 inhibitors

The future of 0:02:21

The future of AML treatment? Progress in IDH1/2 inhibitors for AML

How do targeted 0:01:27

How do targeted treatments for IDH1 and IDH2 mutations work in acute myeloid leukemia (AML)?

The rapid progression 0:02:46

The rapid progression of IDH1/2 mutant enzyme inhibitors through clinical trials

Differentiation Syndrome and 0:02:55

Differentiation Syndrome and IDH1/2 Inhibitors

IDH Inhibitors for 0:08:50

IDH Inhibitors for AML

The efficacy of 0:03:57

The efficacy of FLT3 and IDH1/2 inhibitors in patients with AML previously treated with venetoclax

IDH inhibitors for 0:01:32

IDH inhibitors for AML and MDS

AML: mutant IDH1 0:02:51

AML: mutant IDH1 inhibitor HMS-101

BAY1436032: IDH1 inhibition 0:03:01

BAY1436032: IDH1 inhibition in IDH1-mutated AML

IDH1 inhibitor ivosidenib 0:01:48

IDH1 inhibitor ivosidenib for the treatment of relapsed/ refractory AML

IDH Mutations in 0:06:14

IDH Mutations in AML

Use of targeted 0:00:44

Use of targeted therapies (FLT3 and IDH 1-2 inhibitors) in various settings

IDH inhibitors 0:01:59

IDH inhibitors

IDH inhibition in 0:02:50

IDH inhibition in AML therapy

Targeting IDH mutations 0:02:57

Targeting IDH mutations for the treatment of AML

The promising role 0:01:53

The promising role of IDH inhibitors in AML